Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory examination and pathological evaluation. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment plans for the treatment and management of the history of malignant bone marrow fibrillation require individual development, usually including pharmacological treatment, rehabilitation prevention, regular follow-up, etc.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the pre-proliferation of malignant bone marrow fibrillation.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.